Paul Smart Clinical Oncology Society of Australia Annual Scientific Meeting 2026

Abstracts this author is presenting:

• Long‑term overall survival follow-up of toripalimab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma — Wednesday Poster Session